Filing Flows

Filing Flows › Companies › Cardio Diagnostics Holdings › Cash flow

Cardio Diagnostics Holdings cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$1.5M in Q3 2026 · −$5.8M over twelve months

Operating cash flow−$1.5M
Free cash flow−$1.5M

Analysis

In Q3 2026, Cardio Diagnostics Holdings generated −$1.5M of operating cash flow. That is $40K more than in Q3 2025 (−$1.6M).

Over the twelve months to Sep 30, 2026, operating cash flow was −$5.8M; the largest uses were operating cash flow ($5.8M), other financing ($337K), other investing ($248K); besides operations, cash came from shares issued ($4.0M); the cash balance fell by $2.4M.

Operating cash flow was −$1.5M against net income of −$1.7M. The largest differences: prepaid and other assets +$162K, stock-based pay +$24K, depreciation & amortization +$6K.

Free cash flow

Cardio Diagnostics Holdings: free cash flow by quarterCardio Diagnostics Holdings: free cash flow by quarter−$1.4MQ4 2024−$1.4MQ1 2025−$1.6MQ2 2025−$1.6MQ3 2025−$1.4MQ4 2025−$1.6MQ1 2026−$1.3MQ2 2026−$1.5MQ3 2026
Operating cash flow less capital spending.
Cardio Diagnostics Holdings: operating cash flow against capital spendingCardio Diagnostics Holdings: operating cash flow against capital spendingOperating cash flowCapital spending−$1.4M$4KQ4 2024−$1.4M$6KQ1 2025−$1.6M$19KQ2 2025−$1.4M$163KQ3 2025−$1.4M$0Q4 2025−$1.6M$2KQ1 2026−$1.3M$0Q2 2026−$1.5M$0Q3 2026
Latest (Q3 2026): Operating cash flow −$1.5M, Capital spending $0.

Capital allocation, year by year

Cardio Diagnostics Holdings: where the cash came from (up) and went (down), by fiscal yearCardio Diagnostics Holdings: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2021: Operating cash flow −$585KFY2021: Shares issued $1.1M$1.1MFY2021FY2022: Operating cash flow −$5.1MFY2022: Shares issued $12.0M$12.0MFY2022FY2023: Operating cash flow −$5.7MFY2023: Net borrowing $4.5MFY2023: Capital spending −$576K$4.5MFY2023FY2024: Operating cash flow −$5.0MFY2024: Shares issued $12.4MFY2024: Capital spending −$215K$12.4MFY2024FY2025: Operating cash flow −$5.7MFY2025: Shares issued $3.8MFY2025: Capital spending −$187K$3.8MFY2025
Over these 5 years operating cash flow totalled −$22.1M; the largest uses were operating cash flow ($22.1M) and capital spending ($978K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$0
Debtnone
Net cash$0

Cardio Diagnostics Holdings's operations consume cash (free cash flow −$5.8M a year), and no cash balance is on file to set against it.

Where the cash came from and went

Cardio Diagnostics Holdings: sources (+) and uses (−) of cash, Q3 2026Cardio Diagnostics Holdings: sources (+) and uses (−) of cash, Q3 2026Cash drawn (+) / kept (−)$1.6MOperating cash flow−$1.5MOther financing−$67KOther investing−$60K
Cardio Diagnostics Holdings: sources (+) and uses (−) of cash, TTM to Q3 2026Cardio Diagnostics Holdings: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow−$5.8MShares issued$4.0MCash drawn (+) / kept (−)$2.4MOther financing−$337KOther investing−$248KCapital spending−$2K

From profit to cash

Cardio Diagnostics Holdings: net income to operating cash flow, Q3 2026Cardio Diagnostics Holdings: net income to operating cash flow, Q3 2026Net income−$1.7MDepreciation & amortization$6KStock-based pay$24KReceivables$355Payables−$3KPrepaid and other assets$162KOperating cash flow−$1.5M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026−$1.5M——$1.6M−$1.5M
Q2 2026−$1.3M——$1.5M−$1.3M
Q1 2026−$1.6M−$2K$3.7M−$2.0M−$1.6M
Q4 2025−$1.4M—$263K$1.2M−$1.4M
Q3 2025−$1.4M−$163K$117K$1.6M−$1.6M
Q2 2025−$1.6M−$19K—$1.7M−$1.6M
Q1 2025−$1.4M−$6K$3.4M−$1.9M−$1.4M
Q4 2024−$1.4M−$4K$7.4M−$5.8M−$1.4M

Cardio Diagnostics Holdings: income statement and cash flow

Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year). The chart follows the revenue to costs, profit and cash.

Cardio Diagnostics Holdings: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.